Targeting AMPK/PI3K/AKT/mTOR pathway ameliorates kidney injury induced by type 2 diabetes

Nahla Hussien1, Yasmine Gamal Sabry1, Ansam Aly Seif1

  • 1Physiology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

Insights

Nigella sativa (NS) ameliorates kidney injury in type 2 diabetes (T2D) by modulating the AMPK/PI3K/AKT/mTOR pathway. This natural compound demonstrates significant antidiabetic, antihyperlipidemic, and renoprotective effects in T2D models.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Nephrology

Background:

  • Type 2 diabetes (T2D) is a major cause of chronic kidney disease.
  • The AMPK/PI3K/AKT/mTOR pathway plays a critical role in T2D-related kidney injury.
  • Nigella sativa (NS) is a traditional herb with potential therapeutic properties.

Purpose of the Study:

  • To investigate the renoprotective effects of Nigella sativa (NS) in a rat model of type 2 diabetes (T2D).
  • To elucidate the role of the AMPK/PI3K/AKT/mTOR signaling pathway in T2D-induced kidney damage and the impact of NS treatment.

Main Methods:

  • Induction of T2D in rats and treatment with Nigella sativa (NS).
  • Assessment of renal function, lipid profile, glucose metabolism, and insulin resistance.
  • Analysis of gene expression for AMPK, PI3K, AKT, mTOR, HIF-1α, and VEGF via RT-qPCR.
  • Histopathological examination of kidney tissues using H&E staining.

Main Results:

  • T2D rats exhibited hyperglycemia, dyslipidemia, impaired renal function, and microalbuminuria.
  • T2D led to altered expression of AMPK/PI3K/AKT/mTOR pathway components and increased HIF-1α and VEGF.
  • NS treatment significantly improved biochemical parameters and reversed histopathological damage in T2D rats.
  • NS normalized the expression of key signaling molecules, indicating pathway modulation.

Conclusions:

  • Nigella sativa (NS) exerts significant renoprotective, antidiabetic, and antihyperlipidemic effects in type 2 diabetes (T2D).
  • The beneficial effects of NS are associated with the modulation of the AMPK/PI3K/AKT/mTOR signaling pathway.
  • NS holds promise as a therapeutic agent for managing diabetic nephropathy.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.9K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
387
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
407
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.7K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
529